To improve security and privacy, we are moving our web pages and services from HTTP to HTTPS.
To give users of web services time to transition to HTTPS, we will support separate HTTP and HTTPS services until the end of 2017.
From January 2018 most HTTP traffic will be automatically redirected to HTTPS. [more...]
View this page in https

Cellosaurus PEO23 (CVCL_2689)

Cell line name PEO23
Synonyms PE023
Accession CVCL_2689
Resource Identification Initiative To cite this cell line use: PEO23 (RRID:CVCL_2689)
Comments Part of: OCCP ovarian cancer cell line panel.
Doubling time: ~120 hours (ECACC).
Disease Ovarian cystadenocarcinoma (NCIt: C5228)
Derived from metastatic site: Ascites.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_2687 ! PEO14
CVCL_2734 ! TO14
Sex of cell Female
Category Cancer cell line
STR profile Source(s): ECACC; PubMed=25230021

Markers:
AmelogeninX
CSF1PO11
D13S31711,12
D16S53911
D18S5115
D19S43314,15
D21S1127,30
D2S133824
D3S135816
D5S81811,12 (ECACC)
12 (PubMed=25230021)
D7S8209,10
D8S117913,14
FGA20
Penta D9,13
Penta E10
TH016
TPOX8,11
vWA15,16
Publications

PubMed=3167863
Langdon S.P., Lawrie S.S., Hay F.G., Hawkes M.M., McDonald A., Hayward I.P., Schol D.J., Hilgers J., Leonard R.C.F., Smyth J.F.
Characterization and properties of nine human ovarian adenocarcinoma cell lines.
Cancer Res. 48:6166-6172(1988)

PubMed=20581869; DOI=10.1038/onc.2010.245
Cooke S.L., Ng C.K.Y., Melnyk N., Garcia M.J., Hardcastle T., Temple J., Langdon S.P., Huntsman D., Brenton J.D.
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.
Oncogene 29:4905-4913(2010)

PubMed=23415752; DOI=10.1016/j.molonc.2012.12.007
Stordal B., Timms K., Farrelly A., Gallagher D., Busschots S., Renaud M., Thery J., Williams D., Potter J., Tran T., Korpanty G., Cremona M., Carey M., Li J., Li Y., Aslan O., O'Leary J.J., Mills G.B., Hennessy B.T.
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.
Mol. Oncol. 7:567-579(2013)

PubMed=25230021; DOI=10.1371/journal.pone.0103988
Beaufort C.M., Helmijr J.C.A., Piskorz A.M., Hoogstraat M., Ruigrok-Ritstier K., Besselink N., Murtaza M., van IJcken W.F.J., Heine A.A.J., Smid M., Koudijs M.J., Brenton J.D., Berns E.M.J.J., Helleman J.
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.
PLoS ONE 9:E103988-E103988(2014)

Cross-references
Cell line collections ECACC; 10032313
Ximbio; 151677
Ontologies EFO; EFO_0005447
Gene expression databases GEO; GSM459857